Two dominant host resistance genes to pre-B lymphoma in wild-derived inbred mouse strain MSM/Ms

Cancer Research

Volumn 56, Issue 16, 1996, Pages 3716-3720

  Pataer, Abujiang ^a   Kamoto, Toshiyuki ^a   Lu, Ling Min ^a   Yamada, Yoshihiro ^a   Hiai, Hiroshi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME 15; CHROMOSOME 18; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEGREGATION; HYBRID; INBRED STRAIN; LYMPHOMA; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS EXPRESSION;

ANIMALS; CHROMOSOME MAPPING; FEMALE; GENES, DOMINANT; LEUKEMIA VIRUS, MURINE; LYMPHOMA, B-CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED STRAINS;

EID: 0029783871     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Hiai, H., Kaneshima, H., Nakamura, H , Oguro, Y B , Moriwaki K., and Nishizuka, Y. Unusually early and high rate of spontaneous occurrence of nonthymic leukemias in SL/Kh mice, a subline of SL strain Jpn J Cancer Res , 73: 704-712, 1982.
2. Hiai, H., Buma, Y O , Ikeda, H., Moriwaki, K , and Nishizuka, Y. Epigenetic control of endogenous ecotropic virus expression in SL/Ni strain mice J Natl. Cancer Inst., 79: 781-787, 1987.
3. Ogawa, M. S., Yamada, Y , Nakakuki, Y., Okamoto, K , Fukumoto, M., Honjo, T , and Hiai, H SL/Kh strain mice: a model of spontaneous pre-B lymphomas Leuk. Res , 17: 573-578, 1994.
4. Yamada, Y., Matsushiro, H., Ogawa, M. S., Okamoto, K , Nakakuki, Y., Toyokuni, M., Fukumoto, M., and Hiai, H. Genetic predisposition to pre-B lymphomas in SL/Kh strain mice. Cancer Res , 54, 403-407, 1994.
5. Yamada, Y , Shisa, H , Matsushiro, H., Kamoto, T., Kobayashi, Y., Kawarai, A., and Hiai, H T-lymphomagenesis is determined by a dominant host gene thymic lymphoma susceptible mouse-1 (Tlsm-1) in mouse models. J Exp. Med , 180: 2155-2162, 1994.
6. Kamoto, T., Shisa, H , Abujiang, P , Lu, L-M , Yamada, Y., and Hiai, H A quantitative trait locus in major histocompatibility complex determining latent period of mouse lymphomas. Jpn. J. Cancer Res., 87 401-404, 1996.
7. Lilly, F , and Pincus, T Genetic control of murine viral leukemogenesis. Adv . Cancer Res., 17: 231-277, 1973
8. Potter, M , Wiener, F , and Mushinski, J F. Recent development in plasma-cytomagenesis in mice In: G Klein (ed), Advances in Viral Oncology, Mechanism of Neoplastic Transformation at the Cellular Level, Vol 4, pp. 139-162 New York. Raven Press, Ltd , 1984.
9. Mock, B A., Krall, M. M., and Dosik, J K. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. Proc. Natl. Acad Sci USA, 90: 9499-9504, 1993
10. Sagai, T., Sakaizumi, M., Miyashita, N , Bonhomme, F., Petras, M L., and Monwaki, K. New evidence for trans-species evolution of the H-2 class I polymorphism Immunogenetics, 30 89-98, 1989
11. Abujiang, P , Yamada, Y , Haller, O , Kobayashi, H., Kamoto, T., Lu, L-M., Ogawa, M. S , Ishimoto, A , Katoh, H , Kanehira, K., Ikegami, S , Fukumoto, M , and Hiai, H. The origin of SL family mice. Lab. Anim Sci , in press, 1996
12. Odaka, T, Ikeda, H. Yoshikuro, H , Moriwaki, K , and Suzuki, J Fv-4 gene controlling resistance to NB-tropic Friend murine leukemia virus Distribution in wild mice, introduction into genetic background of BALB/c mice, and mapping of chromosomes J. Natl. Cancer Inst., 67: 1123-1127, 1981
13. Pattengale, P. K., and Taylor, C. R. Experimental models of lymphoproliferative disease. Am J. Pathol , 113: 237-265, 1983.
14. Ikeda, H., and Okada, T. Cellular expression of murine leukemia virus gp70 related antigen on thymocytes of uninfected mice correlates with Fv-4 gene controlled resistance to Friend leukemia virus infection. Virology, 128: 127-130, 1983.
15. Chan, H. W., Bryan, T., Moore, J. L , Stall, S. P , Rowe, W P., and Martin, M. A. Identification of ecotropic proviral sequence in inbred mouse strain with a cloned subgenomic DNA fragment Proc. Natl. Acad. Sci. USA, 77: 5779-5783, 1980.
16. Forejt, J., Artzt K., Barlow, D. P., Hamvas, R M. J., Lindall, K. F., Lyon, M. F., Klein, J., and Silver, L. M. Mouse chromosome 17. Mamm. Genome, 5: S238-S258, 1994.
17. Johnson, K. R., and Davisson, M. T Mouse chromosome 18. Mamm. Genome, 5: S259-S265, 1994
18. n strains of mice. J. Exp. Med., 136: 1272-1285, 1972.
19. b strains of mice. J. Exp. Med., 136, 1286-1301, 1972
20. Rowe, W. P., and Hartly, J. W. Genes affecting mink cell focus-inducing (MCF) murine leukemia virus infection and spontaneous lymphoma in AKR F1 hybrids. J. Exp. Med., 158: 353-364, 1983.
21. Stoye, J. P., Kaushik, N., Jeremiah, S , and Best, S. Genetic map of the region surrounding the retrovirus restriction locus, Fv1, on mouse chromosome 4. Mamm Genome, 6: 31-36, 1995.
22. Melarnedoff, M., Lilly, F., and Duran-Reynals, M. L Suppression of endogenous murine leukemia virus by maternal resistance factor. J. Exp Med , 158: 506-514, 1983
23. Chesebro, B., and Wehrly, K. Rfv-1 and Rfv-2. two H-2 associated genes that influence recovery from Friend leukemia virus-induced splenomegaly. J Immunol., 120; 1081-1085, 1978.
24. Lilly, F. The inheritance of susceptibility to the Gross leukemia virus in mice. Genetics, 53: 529-539, 1966.
25. Debre, P., Gisselbrecht, S., Pozo, F., and Levy, J. P. Genetic control of sensitivity to Moloney leukemia virus in mice II Mapping of three resistant genes within the H-2 complex. J. Immunol., 123; 1806-1812, 1979.
26. Lonai, P., and Haran-Ghera, N. Resistance genes to murine leukemia in the immune response gene region of the H-2 complex. J. Exp Med , 146: 1164-1168, 1977.
27. Whitmore, A. C., Babcock, G. F., and Haughton, G. Genetic control of susceptibility to Rous sarcoma virus tumorigenesis. H. Segregation analysis of strain A.SW-associated resistance to primary tumor induction. J. Immunol, 121: 213-220, 1978.
28. Budowle, B., Acton, R T., Barger, B. O., Blackstick, R., Crisy, W., Go, R C P, Hunphrey, G. B., Ragab, A., Roper, M , Vietti, T , and Dearth, J. Properdin factor B and acute lymphoblastic leukemia (ALL). Cancer (Phila), 50: 2369-2371, 1982.
29. Klein, J , Figueroa, F., and David, C. S. H-2 haplotypes, genes, and antigens second listing. II. The H-2complex. Immunogenetics, 17: 553-596, 1983.
30. Nadeau, J H , and Phillips, S L. The putative oncogene Pim-1 in the mouse its linkage and variation among t-haplotype. Genetics, 117, 533-541, 1987.
31. Cuypers, H. T., Selten, G., Quint, W., Zijstra, M., Maandag, E. R., Boelens, W , van Wezenbeek, P., Melief, C., and Berns, A Munne leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region Cell, 37 141-150, 1984
32. Berns, A. Tumorigenesis in transgenic mice identification and characterization of synergizing oncogenes. J. Cell. Biochem., 47, 130-135, 1991.
33. Smigorena, S., Drake, J., Webster, P , and Mellman, I. Transient accumulation of new class H MHC molecules in a novel endocytic compartment in B lymphocytes Nature (Lond), 369: 113-129, 1994.
34. Wilbur, S. M , and Bonavida, B Expression of hybrid Ia molecules on the cell surface of reticulum cell sarcomas that are undetectable on host SJL/J lymphocytes J. Exp Med, 153: 501-513, 1981
35. Van Lohuizen, M., Verbeek, S , Scheijen, B., Wientjens, E , Van der Gulden, H., and Berns, A Identification of cooperating oncogenes in Eμ-myc transgenic mice by proviral tagging. Cell, 65: 737-742, 1991.
36. Koch, N., and Harris, A. Differential expression of the invariant chain in mouse tumor cells: Relationship to B lymphoid development. J. Immunol, 132: 12-15, 1984.
37. Kyoizumi, S., Noro, N., Teshigawara, K., Sakaguchi, S., and Masuda, T. A cloned cell line, MK1, possessing Ia antisens and accessory cell activity. J Immunol., 128: 2586-2594, 1982
38. Sola, B , Simon, D., Mattei, M. G., Fichelson, S., Bordereaux, D., Guenet, J. L , Tambourin, P E., and Gisselbrecht, S. Fim-1, Fim-2/c-fms, and Fim-3. three common integration sites of Friend murine leukemia virus in myeloblastic leukemias, map to mouse chromosome 13.18, and 3, respectively. J. Virol., 62: 3973-3978, 1988.
39. Gisselfarecht, S., Fichelson, S., Sola, B., Bordereaux, D., Hampe, A , Andre, C , Galibert, F , and Tambourin, P. Frequent c-fms activation by proviral insertion in mouse myeloblastic leukemias. Nature (Lond.), 329: 259-261, 1987.
40. Goyert, S. M., Ferrew, E., Rettig, W. J., and Le-Beau, M. M. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors Science (Washington DC), 259; 497-500, 1988
41. Justice, M. J., Gilbert, D J , Kinzler, K. W., Vogelstein, B., Buchberg, A. M., and Makris, A A molecular genetic linkage map of mouse chromosome 18 reveals extensive linkage conservation with human chromosome 5 and 8. Genomics, 13: 1281-1288, 1992
42. Le-Beau, M. N., and Rowley, J. D. The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q. Proc. Natl Acad. Sci. USA, 84: 5913-5917, 1987.
43. Sariban, E , Mitchell, T., and Kufe, D. Expression of the c-fms proto-oncogene during human monocytic differentiation Nature (Lond.), 310 64-66, 1985.
44. Le-Beau, M. M , Westbrook, K. A , Diaz, M O , Larson, R A., Rowley, J D, Gasson, J. C., and Sherr, C. J. Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders. Science (Washington DC), 231: 984-987, 1986